ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $594,000 | -23.7% | 205,519 | 0.0% | 0.00% | – |
| Q4 2019 | $779,000 | +2.1% | 205,519 | +37.8% | 0.00% | – |
| Q3 2019 | $763,000 | -18.6% | 149,089 | -1.3% | 0.00% | – |
| Q2 2019 | $937,000 | -12.8% | 151,069 | 0.0% | 0.00% | – |
| Q1 2019 | $1,074,000 | +14.0% | 151,069 | +36.9% | 0.00% | – |
| Q4 2018 | $942,000 | -57.4% | 110,338 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $2,209,000 | -52.6% | 110,338 | -19.8% | 0.00% | -50.0% |
| Q4 2017 | $4,661,000 | +59.3% | 137,524 | -0.5% | 0.00% | +100.0% |
| Q3 2017 | $2,926,000 | +19.1% | 138,224 | -1.6% | 0.00% | 0.0% |
| Q2 2017 | $2,457,000 | +11.9% | 140,481 | +11.9% | 0.00% | 0.0% |
| Q1 2017 | $2,196,000 | +2.7% | 125,494 | -0.8% | 0.00% | 0.0% |
| Q4 2016 | $2,138,000 | +33.6% | 126,494 | +29.7% | 0.00% | 0.0% |
| Q3 2016 | $1,600,000 | +74.5% | 97,500 | +61.0% | 0.00% | 0.0% |
| Q2 2016 | $917,000 | +7.0% | 60,550 | +2.2% | 0.00% | 0.0% |
| Q1 2016 | $857,000 | -56.4% | 59,250 | -14.6% | 0.00% | 0.0% |
| Q4 2015 | $1,966,000 | +1056.5% | 69,411 | +585.5% | 0.00% | – |
| Q3 2015 | $170,000 | – | 10,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|